Investigations of the ‘active’ edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin
暂无分享,去创建一个
M. GOODFIELD | S. MACDONALD HULL | D. HOLLAND | G. ROBERTS | E. WOOD | S. REID | W. CUNLIFFE | M. Goodfield | D. Holland | G. Roberts | S. Hull | M. Goodfield | W. Cunliffe | E. Wood | S. Reid | S. Macdonald Hull | Edward J. Wood
[1] I. Hunter,et al. Protein modifications during the keratinization of normal and psoriatic human epidermis. , 1978, Biochimica et biophysica acta.
[2] James T. Elder,et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.
[3] J. B. Ross. THE PSORIATIC CAPILLARY , 1964 .
[4] W. Cunliffe,et al. Modification of human prekeratin during epidermal differentiation. , 1981, The Biochemical journal.
[5] B. Haynes,et al. Monoclonal antibody 4F2 reactive with basal layer keratinocytes: studies in the normal and a hyperproliferative state. , 1984, The Journal of investigative dermatology.
[6] J. Bos,et al. The pathomechanisms of psoriasis; the skin immune system and cyclosporin , 1988, The British journal of dermatology.
[7] L. Nanney,et al. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. , 1986, The Journal of investigative dermatology.
[8] F. Kerdel,et al. The mast cell in health and disease. , 1990, Journal of the American Academy of Dermatology.
[9] W. Cunliffe,et al. Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis. , 1983, Biochimica et biophysica acta.
[10] Benjamin Geiger,et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.
[11] P. V. D. van de Kerkhof,et al. Markers for proliferation and keratinization in the margin of the active psoriatic lesion. , 1990, The British journal of dermatology.
[12] D. Macdonald,et al. Human cutaneous mast cells–a study of fixative and staining reactions in normal skin , 1989, The British journal of dermatology.
[13] B. Bernard,et al. Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology. , 1990, The Journal of investigative dermatology.
[14] J. B. Ross,et al. THE PSORIATIC CAPILLARY: ITS NATURE AND VALUE IN THE IDENTIFICATION OF THE UNAFFECTED PSORIATIC. , 1964, The British journal of dermatology.
[15] W. Cunliffe,et al. Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser--Doppler flowmetry and immunocytochemical techniques. , 1989, The Journal of investigative dermatology.
[16] B. Nickoloff,et al. Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. , 1988, Archives of dermatology.
[17] C. Hodgson,et al. THE UPTAKE OF 3H‐THYMIDINE BY EPIDERMAL CELLS IN NORMAL AND PSORIATIC SUBJECTS. , 1966, The British journal of dermatology.
[18] J. Voorhees,et al. Cyclic nucleotide levels in psoriatic and normal keratomed epidermis. , 1979, The Journal of investigative dermatology.
[19] J. Voorhees,et al. Decreased protein kinase C activity in psoriatic versus normal epidermis. , 1987, The Journal of investigative dermatology.
[20] E. Jong,et al. Markers for proliferation and keratinization in the margin of the active psoriatic lesion , 1990 .
[21] G. Krueger,et al. Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. , 1981, Journal of Clinical Investigation.
[22] D. Ruiter,et al. Monoclonal antibody-defined human endothelial antigens as vascular markers. , 1989, The Journal of investigative dermatology.
[23] I. Braverman,et al. Role of the microcirculation in the treatment and pathogenesis of psoriasis. , 1982, The Journal of investigative dermatology.